• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

The smoldering myeloid leukemic states: clinical and biologic features.

作者信息

Greenberg P L

出版信息

Blood. 1983 Jun;61(6):1035-44.

PMID:6340754
Abstract
摘要

相似文献

1
The smoldering myeloid leukemic states: clinical and biologic features.
Blood. 1983 Jun;61(6):1035-44.
2
Clinical utility of bone marrow culture.骨髓培养的临床应用
Hamatol Bluttransfus. 1976;19:79-90. doi: 10.1007/978-3-642-87524-3_8.
3
Culture studies in vitro in human leukemia.
Semin Hematol. 1978 Oct;15(4):352-78.
4
Behavior of human leukemic progenitor populations in long-term marrow culture.
Haematol Blood Transfus. 1985;29:163-7. doi: 10.1007/978-3-642-70385-0_36.
5
Regulation of granulopoiesis.粒细胞生成的调节
N Engl J Med. 1974 Dec 26;291(26):1388-95. doi: 10.1056/NEJM197412262912606.
6
[Induction of myelogenous differentiation: a therapeutic possibility for preleukemia and acute leukemia?].
Schweiz Med Wochenschr. 1988 May 7;118(18):669-75.
7
Atypical leukemia--relation to chronic myelomonocytic leukemia.
Acta Pathol Jpn. 1980 May;30(3):465-81. doi: 10.1111/j.1440-1827.1980.tb01343.x.
8
Myeloid dysplasia: the histopathology of preleukemia.
Haematol Blood Transfus. 1981;26:34-7. doi: 10.1007/978-3-642-67984-1_4.
9
Granulocyte colony formation in chronic granulocytic leukemia during stable, accelerated and blastic disease.
Proc Soc Exp Biol Med. 1978 Mar;157(3):337-41. doi: 10.3181/00379727-157-40049.
10
Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.二甲基亚砜及其他极性化合物诱导人早幼粒细胞白血病细胞终末分化
Proc Natl Acad Sci U S A. 1978 May;75(5):2458-62. doi: 10.1073/pnas.75.5.2458.

引用本文的文献

1
Environmental and occupational determinants of myelodysplastic syndrome: A case-control study from Pakistan.环境和职业因素与骨髓增生异常综合征的关系：来自巴基斯坦的一项病例对照研究。
Cancer Rep (Hoboken). 2022 Oct;5(10):e1580. doi: 10.1002/cnr2.1580. Epub 2021 Oct 27.
2
Secondary Myelodysplastic Syndrome May Happen Same as Paraneoplastic Syndrome in a Period of Time and Prior to The Appearance of Malignancy: A case Study of 6 Patients.继发性骨髓增生异常综合征可能在一段时间内与副肿瘤综合征同时发生且早于恶性肿瘤出现：6例患者的病例研究
Int J Hematol Oncol Stem Cell Res. 2013;7(2):30-4.
3
Paroxysmal nocturnal hemoglobinuria clone in a case of myelodysplastic syndrome rapidly progressing to acute leukemia.
1例骨髓增生异常综合征患者中迅速进展为急性白血病的阵发性睡眠性血红蛋白尿克隆。
Indian J Hematol Blood Transfus. 2009 Mar;25(1):33-5. doi: 10.1007/s12288-009-0008-4. Epub 2009 Apr 6.
4
Pathology-important advances in clinical medicine: assessing fetal lung maturity.病理学——临床医学的重要进展：评估胎儿肺成熟度
West J Med. 1984 Jul;141(1):93-4.
5
Serum proteome profiling detects myelodysplastic syndromes and identifies CXC chemokine ligands 4 and 7 as markers for advanced disease.血清蛋白质组分析可检测骨髓增生异常综合征，并将CXC趋化因子配体4和7鉴定为晚期疾病的标志物。
Proc Natl Acad Sci U S A. 2007 Jan 23;104(4):1307-12. doi: 10.1073/pnas.0610330104. Epub 2007 Jan 12.
6
Enhanced growth of myelodysplastic colonies in hypoxic conditions.在缺氧条件下骨髓增生异常集落生长增强。
Exp Hematol. 2007 Jan;35(1):21-31. doi: 10.1016/j.exphem.2006.08.017.
7
Ocular complications in myelodysplastic syndromes as preleukemic disorders.骨髓增生异常综合征作为白血病前期疾病的眼部并发症。
Jpn J Ophthalmol. 2005 Sep-Oct;49(5):377-83. doi: 10.1007/s10384-005-0228-6.
8
Pathogenesis, classification, and treatment of myelodysplastic syndromes (MDS).骨髓增生异常综合征（MDS）的发病机制、分类及治疗
Wien Klin Wochenschr. 2003 Aug 14;115(13-14):515-36. doi: 10.1007/BF03041035.
9
Clinico-hematological profile and natural history of childhood myelodysplastic syndromes.
Indian J Pediatr. 1993 Jul-Aug;60(4):573-81. doi: 10.1007/BF02751436.
10
Use and toxicity of the colony-stimulating factors.集落刺激因子的应用与毒性
Drug Saf. 1993 Jun;8(6):457-68. doi: 10.2165/00002018-199308060-00006.